Cargando…

Enhanced antitumor immune responses via a new agent [(131)I]-labeled dual-target immunosuppressant

ABSTRACT: Radionuclides theranostic are ideal “partners” for bispecific antibodies to explore the immune response of patients and synergistic treatment. A bispecific single-domain antibody-Fc fusion protein, KN046, exhibits a good treatment effect by binding to programmed cell death-ligand 1 (PD-L1)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Chunjuan, Tian, Qiwei, Xu, Xiaoping, Li, Panli, He, Simin, Chen, Jian, Yao, Bolin, Zhang, Jianping, Yang, Ziyi, Song, Shaoli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816240/ https://www.ncbi.nlm.nih.gov/pubmed/36242616 http://dx.doi.org/10.1007/s00259-022-05986-4

Ejemplares similares

Engineering a Smart Agent for Enhanced Immunotherapy Effect by Simultaneously Blocking PD‐L1 and CTLA‐4
por: Jiang, Chunjuan, et al.
Publicado: (2021)

(131)I-Labeled Copper Sulfide-Loaded Microspheres to Treat Hepatic Tumors via Hepatic Artery Embolization
por: Liu, Qiufang, et al.
Publicado: (2018)

A core-shell Au@Cu(2-x)Se heterogeneous metal nanocomposite for photoacoustic and computed tomography dual-imaging-guided photothermal boosted chemodynamic therapy
por: Zhang, Le, et al.
Publicado: (2021)

The combined therapeutic effects of (131)iodine-labeled multifunctional copper sulfide-loaded microspheres in treating breast cancer
por: Liu, Qiufang, et al.
Publicado: (2018)

Red-Light-Activatable AND-Gated Antitumor Immunosuppressant
por: Zhou, Ziqi, et al.
Publicado: (2023)

Antitumor Effect of (131)I-Labeled Anti-VEGFR2 Targeted Mesoporous Silica Nanoparticles in Anaplastic Thyroid Cancer
por: Zhang, Ruiguo, et al.
Publicado: (2019)

Therapy of cervical cancer using (131)I-labeled nanoparticles
por: Li, Wei, et al.
Publicado: (2018)

PET imaging of PARP expression using (68)Ga-labelled inhibitors
por: Wang, Xiangwei, et al.
Publicado: (2023)

Localisation of gastrointestinal cancer with a 131 I labelled monoclonal antibody to CEA.
por: Allum, W. H., et al.
Publicado: (1986)

Radioimmunotherapy of human hepatocellular carcinoma xenografts with 131I-labelled antiferritin antibody.
por: Saiful Alam, A. F.
Publicado: (1991)

Radioimmunotherapy study of (131)I-labeled Atezolizumab in preclinical models of colorectal cancer
por: Zhang, Linhan, et al.
Publicado: (2022)

Radionuclide I-131 Labeled Albumin-Paclitaxel Nanoparticles for Synergistic Combined Chemo-radioisotope Therapy of Cancer
por: Tian, Longlong, et al.
Publicado: (2017)

Radioimmunotherapy of transplanted small cell lung cancer with 131I-labelled monoclonal antibody.
por: Yoneda, S., et al.
Publicado: (1988)

Anti-metastatic effect of (131)I-labeled Buthus martensii Karsch chlorotoxin in gliomas
por: Wu, Shan, et al.
Publicado: (2018)

(131)I–Tositumomab in lymphoma
por: Cheung, M.C., et al.
Publicado: (2009)

Optimal (18)F-FDG PET/CT radiomics model development for predicting EGFR mutation status and prognosis in lung adenocarcinoma: a multicentric study
por: Zuo, Yan, et al.
Publicado: (2023)

Radioiodination and Purification of [(131)I]β-CIT and [(131)I]FP-CIT with an Automated Radiosynthesizer
por: Plhak, Elisabeth, et al.
Publicado: (2022)

Lesion based diagnostic performance of dual phase (99m)Tc-MIBI SPECT/CT imaging and ultrasonography in patients with secondary hyperparathyroidism
por: Li, Panli, et al.
Publicado: (2017)

Gallium-68 Labeling of the Cyclin-Dependent Kinase 4/6 Inhibitors as Positron Emission Tomography Radiotracers for Tumor Imaging
por: Liu, Cheng, et al.
Publicado: (2021)

The Biochemical Target of Flexner Dysentery Somatic Antigen: Studies on the Rat Using Antigen Labeled with I(131)
por: Barnes, Frederick W., et al.
Publicado: (1952)

Selective immunotherapy of small cell cancer xenografts using 131I-labelled SWA11 antibody.
por: Smith, A., et al.
Publicado: (1991)

Combined Therapeutic Effects of (131)I-Labeled and 5Fu-Loaded Multifunctional Nanoparticles in Colorectal Cancer
por: Wu, Pingping, et al.
Publicado: (2020)

A case report of (131)I therapy for Graves’ disease patient with hemiagenesis
por: Liu, Xuehui, et al.
Publicado: (2019)

Engineering of an endogenous hydrogen sulfide responsive smart agent for photoacoustic imaging-guided combination of photothermal therapy and chemotherapy for colon cancer
por: Tian, Qiwei, et al.
Publicado: (2022)

(131)I-metaiodobenzylguanidine ((131)I-MIBG) therapy for residual neuroblastoma: a mono-institutional experience with 43 patients
por: Garaventa, A, et al.
Publicado: (1999)

Dose escalation with repeated intrathecal injections of 131I-labelled MAbs for the treatment of central nervous system malignancies.
por: Kemshead, J. T., et al.
Publicado: (1998)

Radioimmunotherapy for Pancreatic Carcinoma Using (131)I‐Labeled Monoclonal Antibody Nd2 in Xenografted Nude Mice
por: Inui, Akimasa, et al.
Publicado: (1996)

(131)I-labeled polyethylenimine-entrapped gold nanoparticles for targeted tumor SPECT/CT imaging and radionuclide therapy
por: Sun, Na, et al.
Publicado: (2019)

Phenylboronic acid conjugated multifunctional nanogels with (131)I-labeling for targeted SPECT imaging and radiotherapy of breast adenocarcinoma
por: Kong, Lingdan, et al.
Publicado: (2022)

Pharmacological immunosuppressive agents.
por: Salaman, J. R.
Publicado: (1981)

I-131 uptake in fat necrosis of the breast
por: Itani, Malak, et al.
Publicado: (2016)

Toxicity of upfront (131)I-metaiodobenzylguanidine ((131)I-MIBG) therapy in newly diagnosed neuroblastoma patients: a retrospective analysis
por: Bleeker, Gitta, et al.
Publicado: (2013)

(131)I-Caerin 1.1 and (131)I-Caerin 1.9 for the treatment of non-small-cell lung cancer
por: Liu, Na, et al.
Publicado: (2022)

The influence of thionamides on intra-thyroidal uptake of (131)I during radioiodine-131 treatment of Graves’ disease
por: Happel, Christian, et al.
Publicado: (2023)

Iodine-131 labeled genistein as a potential radiotracer for breast cancer
por: Ramdhani, Danni, et al.
Publicado: (2020)

Therapy to target renal cell carcinoma using (131)I-labeled B7-H3 monoclonal antibody
por: Wang, Gongcheng, et al.
Publicado: (2016)

(131)I-Labeled Anti-HER2 Nanobody for Targeted Radionuclide Therapy of HER2-Positive Breast Cancer
por: Zhao, Lingzhou, et al.
Publicado: (2023)

Interventional therapy for human breast cancer in nude mice with (131)I gelatin microspheres ((131)I-GMSs) following intratumoral injection
por: Li, Chuan-Chao, et al.
Publicado: (2014)

Development of [(131)I]I-EOE-TPZ and [(131)I]I-EOE-TPZMO: Novel Tirapazamine (TPZ)-Based Radioiodinated Pharmaceuticals for Application in Theranostic Management of Hypoxia
por: Elsaidi, Hassan, et al.
Publicado: (2019)

Apoptosis gene reprograming of human peripheral blood mononuclear cells induced by radioiodine-131 ((131)I) irradiation
por: Li, Jian-Fang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_s9mmcm8ptg1sl56uq9tpc2d87o